2.2 Controlled Substance Inventory, Theft & Disposal

2.2 Controlled Substance Inventory, Theft & Disposal

MPJE Core Concept: Accountability and auditability form the bedrock of federal controlled substance regulations under 21 CFR Part 1304. Pharmacies must maintain an uninterrupted, accurate record of every controlled substance dosage unit that enters, resides within, or exits the registered facility from the moment of opening until final closure.

---

Initial and Biennial Inventory Requirements

An inventory is a complete and accurate physical count of all controlled substances on hand at the registered location on the date the inventory is conducted.

1. Initial Inventory

• Timing: Must be taken on the first day the pharmacy opens for business.
• Zero Stock Rule: If the pharmacy has no controlled substances in stock on its opening day, the record must indicate a zero count.
• Required Elements: The initial inventory record must include the date, time taken (at opening or close of business), drug names, dosage forms, strengths, quantities, and the signature of the Pharmacist-in-Charge (PIC).

2. Biennial Inventory (Every 2 Years)

Under 21 CFR 1304.11, every registrant must conduct a physical inventory of all controlled substances at least once every two years (biennially) following the initial inventory.

Counting Rules Matrix: Exact Count vs. Estimation

[!IMPORTANT] Inventory Record Maintenance: All controlled substance inventory records must be kept at the registered location for at least 2 years from the inventory date. Records of Schedule I and II inventories MUST be kept completely separate from all other pharmacy records (e.g., in a dedicated C-II binder). Schedule III–V inventory records may be kept separately or in a readily retrievable format.

3. Newly Scheduled Drugs

When a drug is not previously controlled but is added to any DEA schedule (or moved to a higher schedule), the pharmacy must take a physical inventory of that specific drug on the effective date of the scheduling order.

---

Reporting Significant Theft or Loss: DEA Form 106

When controlled substances are stolen or lost, federal law enforces strict notification deadlines to prevent illicit diversion.

1-Business-Day Initial Notification Rule

Under 21 CFR 1301.76(b), a registrant must notify the local DEA Field Division in writing within 1 business day of discovery of any significant theft or loss of controlled substances.

[!CAUTION] Massachusetts State Rule — 247 CMR 20.03(7). A Drug Store pharmacy, sterile compounding pharmacy, complex non-sterile compounding pharmacy or nuclear pharmacy located in Massachusetts must report a theft or loss of a significant amount of controlled substances by submitting to the Board a copy of the Report of Theft or Loss of Controlled Substance and DEA Form 106 within seven days, and must where applicable also comply with the reporting requirements of the DEA, the Department, and the state and local police. Note the two clocks: one business day for the written notice to the local DEA Field Division under 21 CFR 1301.76(b), and seven days for the Board submission.

Factors for Determining "Significant Loss"

The DEA does not define a fixed threshold number of tablets for "significant loss." Instead, registrants must evaluate the following criteria:

1. The specific quantity lost in relation to the pharmacy's total business volume.
2. The specific controlled substances lost (e.g., loss of fentanyl patches vs. cough syrup with codeine).
3. Whether the loss can be linked to specific individuals or access patterns.
4. A pattern of losses occurring over a specific time frame.
5. Whether the lost substances are prime targets for diversion.

Completing DEA Form 106

Following initial written notification within 1 business day, the pharmacy investigates the loss and completes DEA Form 106 (Report of Theft or Loss of Controlled Substances) electronically via the DEA secure portal. Form 106 details the registrant info, date of theft/loss, type of theft (e.g., armed robbery, burglary, employee diversion), local police department notified, and exact itemized list of missing drugs.

In-Transit Losses vs. Breakage / Spillage

• In-Transit Loss: If controlled substances are lost or stolen in transit before the pharmacy accepts delivery, the supplier/wholesaler is responsible for submitting DEA Form 106. Once the pharmacy signs for and accepts the shipment, any subsequent loss is the pharmacy's responsibility.
• Breakage / Spillage: Damage or breakage where the drug is recoverable does NOT constitute a loss. Damaged inventory is transferred to a reverse distributor for disposal. If non-recoverable (e.g., a liquid bottle breaks down a sink drain), the event must be documented in the pharmacy logbook with signatures of two witness employees.

---

Controlled Substance Disposal & Reverse Distributors: DEA Form 41

Pharmacies are strictly prohibited from disposing of controlled substances by flushing them down drains or throwing them in trash receptacles.

Reverse Distributor Process

The standard, lawful method for a retail pharmacy to dispose of expired, damaged, or unwanted controlled substance inventory is transferring the drugs to a DEA-registered reverse distributor.

• Transfer Documentation:
  • Schedule I and II Drugs: The reverse distributor issues an official DEA Form 222 to the pharmacy. In this transaction, the pharmacy acts as the supplier transferring the C-II drugs to the reverse distributor (purchaser).
  • Schedule III, IV, and V Drugs: Transferred via an itemized commercial invoice detailing drug names, dosage forms, strengths, quantities, and transfer date.
• DEA Form 41 (Registrant Record of Controlled Substances Destroyed):
  • DEA Form 41 is NOT completed by the pharmacy when returning drugs to a reverse distributor.
  • The reverse distributor executes the actual destruction and submits completed DEA Form 41 directly to the DEA.

---

Drug Take-Back Programs & SECURE Act (2010)

Passage of the Secure and Responsible Drug Disposal Act of 2010 amended the CSA to authorize ultimate users (patients and family members) to surrender unwanted controlled substances for safe disposal.

Receptacle & Collection Standards

• Collector Registration: Retail pharmacies may modify their DEA registration online to become authorized collectors.
• Collection Receptacle Specifications: Must feature a securely fastened, locked outer steel container with a small slot allowing insertion but preventing retrieval. Inside is a removable, tamper-evident, water-resistant, non-retrievable inner liner.
• Employee Prohibition: Pharmacy staff are strictly prohibited from touching, inspecting, or handling patient-returned controlled substances. The patient must personally deposit the drugs into the slot.
• Liner Disposal Workflow: Two pharmacy employees must monitor the installation, removal, and sealing of inner liners. Sealed liners are recorded in a collection log and shipped to a reverse distributor for destruction.